Enugu Corps member’s death not caused by substandard medicines – NAFDAC

On October 16, 2026, the National Agency for Food and Drug Administration and Control (NAFDAC) issued a statement regarding the death of a corps member in Enugu. The agency clarified that the death was not caused by substandard medicines, as previously speculated, and confirmed that the deceased had been stabilized with intramuscular antimalarial and other supportive medications administered intravenously.

NAFDAC's statement aimed to address concerns surrounding the quality of medicines following the corps member's death. The agency emphasized that the medications provided were appropriate and effective in stabilizing the individual. No specific details were provided about the circumstances leading to the corps member's initial condition or the timeline of events surrounding the treatment and subsequent death.

Reported by Vanguard.